TickerFactsScreenerDevelopers

Cardiff Oncology, Inc. (CRDF) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $58.7K2011: $700.4K2012: $10.82M2013: $25.84M2014: $27.29M2015: $67.49M2016: $13.92M2017: $8.23M2018: $11.45M2019: $10.20M2020: $130.98M2021: $11.94M2022: $16.35M2023: $21.66M2024: $51.47M2025: $17.47M$17.47M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$17.47M-66.1%
2024$51.47M+137.7%
2023$21.66M+32.5%
2022$16.35M+36.9%
2021$11.94M-90.9%
2020$130.98M+1184.7%
2019$10.20M-11.0%
2018$11.45M+39.2%
2017$8.23M-40.9%
2016$13.92M-79.4%
2015$67.49M+147.3%
2014$27.29M+5.6%
2013$25.84M+138.8%
2012$10.82M+1444.9%
2011$700.4K+1093.1%
2010$58.7K—